Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Cleveland, Ohio

Phase 1 cancer trials in Cleveland, OH

78 Phase 1 cancer studies are recruiting participants at sites in Cleveland as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Cleveland at a glance

Breast cancer studies recruiting in Cleveland

Basic details from each study's public record (the 30 most recently updated of 78). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study sites
    Cleveland Clinic · University Hospital Cleveland Medical Center
    Registry record
    NCT06253871 · updated
  2. A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

    • Phase 1
    • Ages 18 to 55
    • Female participants
    Sponsor
    TerSera Therapeutics LLC
    Study site
    Cleveland Clinic Foundation
    Registry record
    NCT07310420 · updated
  3. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    Cleveland Clinic
    Registry record
    NCT07029399 · updated
  4. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    University Hospitals Cleveland Medical Center
    Registry record
    NCT06465069 · updated
  5. A Phase 1 Study of LNCB74 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    LigaChem Biosciences, Inc.
    Study site
    Cleveland Clinic Taussig Cancer Institute
    Registry record
    NCT06774963 · updated
  6. A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Terremoto Biosciences Inc.
    Study site
    UH Cleveland Medical Center
    Registry record
    NCT07109726 · updated
  7. A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genentech, Inc.
    Study site
    Cleveland Clinic Taussig Cancer Center
    Registry record
    NCT07100106 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Cleveland, OH on ClinicalTrials.gov.

Lung cancer studies recruiting in Cleveland

  1. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    Cleveland Clinic
    Registry record
    NCT05786924 · updated
  2. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Case Western Reserve University
    Registry record
    NCT06287775 · updated
  3. A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Novelty Nobility, Inc.
    Study site
    Case Comprehensive Cancer Center
    Registry record
    NCT06805825 · updated
  4. A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center
    Registry record
    NCT07111520 · updated
  5. Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study site
    Cleveland Clinic
    Registry record
    NCT04886804 · updated
  6. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    University Hospitals Cleveland Medical Center
    Registry record
    NCT07397338 · updated
  7. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Cleveland Clinic, Taussig Cancer Institute
    Registry record
    NCT06720987 · updated
  8. A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    UH Cleveland Medical Center
    Registry record
    NCT07542704 · updated
  9. SW-682 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
    Study site
    University Hospital of Cleveland
    Registry record
    NCT06251310 · updated
  10. Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Synthekine
    Study site
    University Hospitals Cleveland
    Registry record
    NCT05098132 · updated
  11. A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Inc
    Study site
    University Hospitals - UH Cleveland Medical Center
    Registry record
    NCT07094204 · updated
  12. A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT06996782 · updated
  13. Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Molecular Partners AG
    Study site
    University Hospitals Cleveland Medical Center
    Registry record
    NCT07278479 · updated
  14. Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    University Hospitals Cleveland Medical Center
    Registry record
    NCT06162221 · updated
  15. A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Zai Lab (Shanghai) Co., Ltd.
    Study site
    University Hospitals Cleveland Medical Center
    Registry record
    NCT06179069 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Cleveland, OH on ClinicalTrials.gov.

Prostate cancer studies recruiting in Cleveland

  1. A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    University Hospitals Cleveland Medical Center
    Registry record
    NCT07082920 · updated
  2. A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    University Hospitals Cleveland Medical Center
    Registry record
    NCT07319871 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Cleveland, OH on ClinicalTrials.gov.

Lymphoma studies recruiting in Cleveland

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    Rainbow Babies and Childrens Hospital
    Registry record
    NCT04726241 · updated
  2. A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University Hospitals of Cleveland ( Site 0113)
    Registry record
    NCT07519772 · updated
  3. A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Cleveland Clinic
    Registry record
    NCT07101328 · updated
  4. Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Case Western Reserve University
    Registry record
    NCT06015880 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Cleveland, OH on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Cleveland

  1. Lead-212 PSV359 Therapy for Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    Cleveland Clinic
    Registry record
    NCT06710756 · updated
  2. JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Jacobio Pharmaceuticals Co., Ltd.
    Study site
    Cleveland Clinic Foundation
    Registry record
    NCT06973564 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Cleveland, OH on ClinicalTrials.gov.

Ask about studies near Cleveland

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Ohio

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call